Helen E. Kent

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Elevated SARS-CoV-2 IgG4 in plasma and mucosa following repeated mRNA boosters impact antibody functions to Omicron and sarbecoviruses.

Elevated SARS-CoV-2 IgG4 in plasma and mucosa following repeated mRNA boosters impact antibody functions to Omicron and sarbecoviruses.

Journal: EBioMedicine
Published: June 11, 2025

Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans.

Blood Distribution of SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine in Humans.

Journal: ACS nano
Published: September 19, 2024

Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccines.

Randomized trial of same- versus opposite-arm coadministration of inactivated influenza and SARS-CoV-2 mRNA vaccines.

Journal: JCI insight
Published: September 13, 2024

Randomized controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccine.

Randomized controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccine.

Journal: The Journal of clinical investigation
Published: March 18, 2024

Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection.

Durable reprogramming of neutralizing antibody responses following Omicron breakthrough infection.

Journal: Science advances
Published: July 21, 2023

Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections.

Preexisting immunity restricts mucosal antibody recognition of SARS-CoV-2 and Fc profiles during breakthrough infections.

Journal: JCI insight
Published: May 22, 2023

Mucosal antibody responses following Vaxzevria vaccination.

Mucosal antibody responses following Vaxzevria vaccination.

Journal: Immunology and cell biology
Published: May 05, 2023

SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses.

SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses.

Journal: Immunity
Published: December 15, 2022

Phenotypic and functional characteristics of highly differentiated CD57+NKG2C+ NK cells in HIV-1-infected individuals.

Phenotypic and functional characteristics of highly differentiated CD57+NKG2C+ NK cells in HIV-1-infected individuals.

Journal: Clinical and experimental immunology
Published: March 22, 2022

The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants.

The magnitude and timing of recalled immunity after breakthrough infection is shaped by SARS-CoV-2 variants.

Journal: Immunity
Published: January 22, 2022

Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory.

Establishment and recall of SARS-CoV-2 spike epitope-specific CD4+ T cell memory.

Journal: Nature immunology
Published: October 05, 2021

Intra-Anal Imiquimod Cream against Human Papillomavirus Infection in Men Who Have Sex with Men Living with HIV: A Single-Arm, Open-Label Pilot Study.

Intra-Anal Imiquimod Cream against Human Papillomavirus Infection in Men Who Have Sex with Men Living with HIV: A Single-Arm, Open-Label Pilot Study.

Journal: Journal of clinical medicine
Published: August 12, 2021
Showing 1-12 of 16

Last Updated: 09/26/2026